Canopy Growth Corp Asset Resilience Ratio
Canopy Growth Corp asset resilience ratio. Canopy Growth Corp (CGC) has an Asset Resilience Ratio of 0.46% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Canopy Growth Corp fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Canopy Growth Corp (2014–2026)
Asset resilience ratio of Canopy Growth Corp from 2014 to 2026. This chart shows how Canopy Growth Corp's Asset Resilience Ratio has changed over time. Read Canopy Growth Corp (CGC) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Canopy Growth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Canopy Growth Corp total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.06 Million | 0.46% |
| Total Liquid Assets | $5.06 Million | 0.46% |
Asset Resilience Insights
- Limited Liquidity: Canopy Growth Corp maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Canopy Growth Corp Industry Peers by Asset Resilience Ratio
Compare Canopy Growth Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Canopy Growth Corp Asset Resilience Ratio by Year (2014–2026)
Canopy Growth Corp asset resilience ratio by year from 2014 to 2026. The table below shows the annual Asset Resilience Ratio data for Canopy Growth Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.45% | $5.06 Million | $1.12 Billion | -1.47pp |
| 2025-03-31 | 1.92% | $17.66 Million | $917.70 Million | -0.63pp |
| 2024-03-31 | 2.55% | $33.16 Million | $1.30 Billion | -1.78pp |
| 2023-03-31 | 4.33% | $105.53 Million | $2.44 Billion | -6.30pp |
| 2022-03-31 | 10.63% | $595.65 Million | $5.61 Billion | -6.42pp |
| 2021-03-31 | 17.04% | $1.16 Billion | $6.82 Billion | +6.91pp |
| 2020-03-31 | 10.13% | $488.19 Million | $4.82 Billion | -13.50pp |
| 2019-03-31 | 23.63% | $2.06 Billion | $8.73 Billion | +23.58pp |
| 2018-03-31 | 0.05% | $664.00K | $1.44 Billion | +0.05pp |
| 2017-03-31 | 0.00% | $0.02 | $677.61 Million | -- |
| 2016-03-31 | 0.00% | $0.00 | $143.36 Million | -- |
| 2015-03-31 | 0.00% | $356.86 | $47.77 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $25.96 Million | -- |
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more